VR Logo

QSAM Biosciences Inc (QSAM) download report


Healthcare | Biotechnology & Pharma Research

QSAM Biosciences Inc (QSAM) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases.

IPO Date: 11-Dec-2015

Co-Founder, CEO & Director: Mr. Douglas R. Baum

Chief Financial Officer: Mr. Adam King CPA

Listing: NASDAQ: QSAM

Country: United States

Headquarters: Austin, TX

Website: https://qsambio.com

Key Facts

Market cap: $7.18 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-10.47 Mln

Cash: $0.87 Mln

Total Debt: $0.55 Mln

Insider's Holding: 58.96%

Liquidity: Low

52 Week range: $4.20 - 20.40

Shares outstanding: 1,686,590

6 Years Aggregate:

  • CFO: $-6.28 Mln
  • EBITDA: $-18.81 Mln
  • Net Profit: $-22.13 Mln

Stock Performance

Time Period QSAM Biosciences Inc (QSAM) S&P BSE Sensex* S&P Small-Cap 600*
YTD-40.83-8.84-19.22
1 month-29.00-3.25-9.34
3 months-55.16-8.35-14.58
1 Year-68.681.05-17.64
3 Years-54.5910.475.91
5 Years-51.8711.475.64
10 Years-58.5211.7810.10
As on 28-Jun-2022 *As on 30-Jun-2022